Actions of human telomerase beyond telomeres

Cell Research

Volumn 18, Issue 7, 2008, Pages 725-732

  Cong, Yusheng ^a   Shay, Jerry W ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aging; Apoptosis; Cancer; DNA damage response; Immortalization

Indexed keywords

RNA; TELOMERASE;

ANIMAL; APOPTOSIS; CELL AGING; DNA REPAIR; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; REVIEW; STEM CELL; TELOMERE;

ANIMALS; APOPTOSIS; CELL AGING; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; RNA; STEM CELLS; TELOMERASE; TELOMERE;

EID: 46749152214     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.74     Document Type: Review

References (79)

1. Müller HJ. The remaking of chromosomes. Collecting Net 1938; 13:181-198.
2. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26:234-282.
3. De lange T, Lundblad V and Blackburn EH. Telomeres. 2nd Edition. Cold Spring Harbor Laboratory Press, 2006.
4. Blackburn EH. Telomere states and cell fates. Nature 2000; 408:53-56.
5. Collins K. The biogenesis and regulation of telomerase holoenzymes. Nature reviews Mol Cell Biol 2006; 7:484-494.
6. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66:407-425.
7. Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26:867-874.
8. Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 2006; 22:531-557.
9. Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 2004; 432:640-645.
10. E600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-724.
11. Collado M, Gil J, Efeyan A, Guerra C et al. Senescence in premalignant tumours. Nature 2005; 436:642.
12. Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-665.
13. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725-730.
14. Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci USA 2007; 104:13028-13033.
15. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-660.
16. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445:661-665.
17. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature 2007; 448:767-774.
18. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-352.
19. Harley CB. Telomerase is not an oncogene. Oncogene 2002; 21:494-502.
20. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 10:1164-1170.
21. Herbert B, Pitts AE, Baker SI, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999; 96:14276-14281.
22. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 1999; 13:2388-2399.
23. Artandi SE. Telomerase, and Human Disease. N Engl J Med 2006; 355:1195-1197.
24. Yamaguchi H, Calado RT, Ly H, et al. Mutations in hTERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005; 352:1413-1424.
25. Tsakiri KD, CronkhiteJT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007; 104:7552-7557.
26. Blasco MA. Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging. EMBO J 2005; 24:1095-1103.
27. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006; 7:577-584.
28. Santos JH, Meyer N, Skorvaga M, et al. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004; 3:399-411.
29. Santos JH, Meyer JN, Van Houten B. Mitochondial localization of telomerase as determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptpsis. Hum Mol Genet 2006; 15:1757-1768.
30. Haendeler J, Hoffmann J, Diehl JF, et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004; 94:768-775.
31. Gorbunova V, Seluanov A, Pereira-Smith OM. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem 2002; 277:38540-38549.
32. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J 2003; 17:767-769.
33. Massard C, Zermati Y, Pauleau AL, et al. hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 2006; 25:4505-4514.
34. Lee J, Sung YH, Cheong C, et al. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 2008 Jan 28; [Epub ahead of print].
35. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-2110.
36. Meier A, Fiegler H, Munoz P, et al. Spreading of mammalian DNA-damage response factors studied by ChIP-chip at damaged telomeres. EMBO J 2007; 26:2707-2718.
37. Verdun RE, Karlseder J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 2006; 127:709-720.
38. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 2004; 6:168-170.
39. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-198.
40. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-1556.
41. Narita M, Nunez S, Heard E, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-716.
42. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114:241-253.
43. Stellwagen AE, Haimberger ZW, Veatch JR, Gottschling DE. Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends. Genes Dev 2003; 17:2384-2395.
44. Ray S, Karamysheva Z, Wang L, Shippen DE, Price CM. Interactions between telomerase and primase physically link the telomere and chromosome replication machinery. Mol Cell Biol 2002; 22:5859-5868.
45. Sharma GG, Hwang KK, Pandita RK, et al. Human heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol Cell Biol 2003; 23:8363-8376.
46. Sharma GG, Gupta A, Wang H, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003; 22:131-146.
47. Masutomi K, Possemato R, Wong JM, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 2005; 102:8222-8227.
48. Shin KH, Kang MK, Dicterow E, Kameta A, Baluda MA, Park NH. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res 2004; 10:2551-2560.
49. Kampinga HH, Van Waarde-Verhagen MA, Van Assen-Bolt AJ, et al. Reconstitution of active telomerase in primary human foreskin fibroblasts: effects on proliferative characteristics and response to ionizing radiation. Int J Radiat Biol 2004; 80:377-388.
50. Bates SE, Zhou NY, Federico LE, Xia L, O'Connor TR. Repair of cyclobutane pyrimidine dimers or dimethylsulfate damage in DNA is identical in normal or telomerase-immortalized human skin fibroblasts. Nucleic Acids Res 2005; 33:2475-2485.
51. Beliveau A, Bassett E, Lo AT. P53-dependent integration of telomere and growth factor deprivation signals. Proc Natl Acad Sci USA 2007; 104:4431-4436.
52. Beliveau A. Soothing the watchman: Telomerase reduces the p53-dependent cellular stress response. Cell Cycle 2007; 6:1284-1287.
53. Stewart SA, Hahn WC, O'Connor BF, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 2002; 99:12606-12611.
54. Sarin KY, Cheung P, Gilison D, et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436:1048-1052.
55. Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005; 309:1253-1256.
56. Wong JM, Kusdra L, Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 2002; 4:731-736.
57. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21:564-579.
58. Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol 2007; 3:640-649.
59. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999; 96:701-712.
60. Riha K, McKnight TD, Griffing LR, Shippen DE. Living with genome instability: plant responses to telomere dysfunction. Science 2001; 291:1797-1800.
61. Cheung I, Schertzer M, Rose A, Lansdorp PM. High incidence of rapid telomere loss in telomerase-deficient Caenorhabditis elegans. Nucleic Acids Res 2006; 34:96-103.
62. Choi J, Southworth LK, Sarin KY, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 2008; 4:e10. Epub 2007 Dec 13.
63. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
64. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
65. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451:141-146.
66. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003; 5:474-479.
67. Perrault SD, Hornsby PT, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun 2005; 335:925-936.
68. Lindvall C, Hou M, Komurasaki T, et al. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the Epiregulin gene. Cancer Res 2003; 63:1743-1747.
69. Bagheri S, Nosrati M, Li S, et al. Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA 2006; 103:11306-11311.
70. Li S, Crothers J, Haqq CM, Blackburn EH. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 2005; 280:23709-23717.
71. Park YP, Choi SC, Kim JH, et al. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 2007; 120:813-820.
72. Jagadeesh S, Banerjee PP. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commu 2006; 347:774-780.
73. Yonng JI, Sedivy JM, Smith JR. Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I. J Biol Chem 2003; 278:19904-19908.
74. Akiyama M, Hideshima T, Hayashi T, et al. Nuclear Factor-κB p65 mediates tumor necrosis factor α-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 2003; 63:18-21.
75. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev 1998; 12:1769-1774.
76. Wang J, Hannon GJ, Heach DH. Risky immortalization by telomerase. Nature 2000; 405:755-756.
77. Xiang H, Wang J, Mao Y, et al. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway. Oncogene 2002; 21:3784-3791.
78. Lai SR, Cunningham AP, Huynh VQ, et al. Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. Exp Cell Res 2007; 313:322-330.
79. Liu C, Fang X, Ge Z, et al. The telomerase reverse transcriptase (hTERT) gene is direct target of histone methyltransferase SMYD3. Cancer Res 2007; 67:2626-2631.